NCT04588545 2026-05-26Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal DiseaseH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Active not recruiting33 enrolled